Cargando…
Psoriatic clearance during haemodialysis.
Autores principales: | McEvoy, J., Kelly, A. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Ulster Medical Society
1976
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2385567/ https://www.ncbi.nlm.nih.gov/pubmed/936361 |
Ejemplares similares
-
Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
por: Elewski, Boni E., et al.
Publicado: (2022) -
Takotsubo Syndrome during Haemodialysis
por: Tsigaridas, Nikolaos, et al.
Publicado: (2019) -
Efficacy of enoxaparin in preventing coagulation during high-flux haemodialysis, expanded haemodialysis and haemodiafiltration
por: Santos, Alba, et al.
Publicado: (2020) -
A Pharmacokinetic Study Comparing the Clearance of Vancomycin during Haemodialysis Using Medium Cut-Off Membrane (Theranova) and High-Flux Membranes (Revaclear)
por: Allawati, Hussain, et al.
Publicado: (2020) -
Pilot Study of a Wearable Hydration Monitor in Haemodialysis Patients: Haemodialysis Outcomes & Patient Empowerment Study 02
por: Sandys, Vicki, et al.
Publicado: (2023)